Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab Medical Dialogues Bureau28 Jun 2019 12:30 PM ISTThe initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...
Johnson and Johnson psoriasis drug gets expanded US approval for teens Ruby Khatun Khatun15 Oct 2017 9:47 AM ISTJohnson and Johnson said on Friday it has received an expanded U.S. approval for its blockbuster psoriasis drug Stelara to treat adolescent patients...
Novartis Cosentyx sets new benchmark in psoriasis with robust 5-year sustained Phase III efficacy and safety data Ruby Khatun Khatun21 Sept 2017 9:57 AM ISTBasel, September 13, 2017 - Novartis announced, first of its kind Phase III data showing Cosentyx® (secukinumab) delivered high and long-lasting skin...
